Mitchell A. deLong
Impact in
- Ophthalmology top 2%
- Glaucoma and retinal disorders
- Retinal Diseases and Treatments
- Dermatology top 5%
- Skin Protection and Aging
- Dermatologic Treatments and Research
Papers in
- Pharmacology 10
- Flavonoids in Medical Research 5
- Inflammatory mediators and NSAID effects 4
- Co-authors
- Raymond E. Boissy (4 shared papers)Marty O. Visscher (3 shared papers)Casey Kopczynski (11 shared papers)Cheng‐Wen Lin (8 shared papers)Bryan W. Sherman (5 shared papers)Carmen Laethem (4 shared papers)R. Randall Wickett (3 shared papers)Ponugoti Vasantha Rao (1 shared paper)
- Journals
- Journal of Medicinal Chemistry (4 papers)Investigative Ophthalmology & Visual Science (3 papers)Bioorganic & Medicinal Chemistry Letters (2 papers)Archives of Biochemistry and Biophysics (2 papers)Journal of Ocular Pharmacology and Therapeutics (2 papers)
- Partner nations
- United StatesCanadaTaiwan
In The Last Decade
Mitchell A. deLong
26 papers receiving 651 citations
Peers
Comparison fields: 5 of 67
- Ophthalmology 187
- Dermatology 124
- Cell Biology 221
- Sensory Systems 30
- Nutrition and Dietetics 91
Countries citing papers authored by Mitchell A. deLong
This map shows the geographic impact of Mitchell A. deLong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitchell A. deLong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitchell A. deLong more than expected).
Fields of papers citing papers by Mitchell A. deLong
This network shows the impact of papers produced by Mitchell A. deLong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitchell A. deLong. The network helps show where Mitchell A. deLong may publish in the future.
Co-authors
The 25 scholars most cited alongside Mitchell A. deLong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 132 | |
| 2 | 2005 | 117 | |
| 3 | 2016 | 82 | |
| 4 | 1990 | 72 | |
| 5 | 2008 | 50 | |
| 6 | 1999 | 49 | |
| 7 | Comparative efficacy and safety of deoxyarbutin, a new tyrosinase-inhibiting agent. | 2006 | 41 |
| 8 | 2000 | 25 | |
| 9 | DeoxyArbutin and its derivatives inhibit tyrosinase activity and melanin synthesis without inducing reactive oxygen species or apoptosis. | 2012 | 15 |
| 10 | 2000 | 15 | |
| 11 | 2001 | 12 | |
| 12 | Discovery and in vitro SAR of AR-12286, a Potent Kinase Inhibitor for the Treatment of Glaucoma | 2009 | 8 |
| 13 | 2022 | 7 | |
| 14 | 2003 | 7 | |
| 15 | 2000 | 6 | |
| 16 | 2000 | 5 | |
| 17 | 2000 | 5 | |
| 18 | 2007 | 5 | |
| 19 | Discovery and SAR of a Class of Ocularly-active Compounds Displaying a Dual Mechanism of Activity for the Treatment of Glaucoma | 2012 | 5 |
| 20 | 2023 | 4 |
About Mitchell A. deLong
Mitchell A. deLong is a scholar working on Pharmacology, Organic Chemistry, Molecular Biology, Ophthalmology and Cell Biology, having authored 29 papers that have together received 676 indexed citations. Recurring topics across this work include Glaucoma and retinal disorders (7 papers), Flavonoids in Medical Research (5 papers), Inflammatory mediators and NSAID effects (4 papers), Bone health and treatments (4 papers), melanin and skin pigmentation (4 papers), Biochemical Analysis and Sensing Techniques (3 papers), Skin Protection and Aging (3 papers) and Hemoglobin structure and function (2 papers). The work is most often cited by research in Ophthalmology (187 citations), Dermatology (124 citations), Cell Biology (221 citations), Sensory Systems (30 citations) and Nutrition and Dietetics (91 citations). Mitchell A. deLong has collaborated with scholars based in United States, Canada and Taiwan. Frequent co-authors include Raymond E. Boissy, Marty O. Visscher, Casey Kopczynski, Cheng‐Wen Lin, Bryan W. Sherman, Carmen Laethem, R. Randall Wickett, Ponugoti Vasantha Rao, Da‐Wen Lu and Padmanabhan P. Pattabiraman. Their work appears in journals such as Journal of Medicinal Chemistry, Investigative Ophthalmology & Visual Science, Bioorganic & Medicinal Chemistry Letters, Archives of Biochemistry and Biophysics and Journal of Ocular Pharmacology and Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.